A Privacy-Preserving Zero-Code Conversational Statistical Analysis System for Clinical Research Using Agentic AI and Local R Execution
Shujie Yang, Vincent Chen, Wee Han Ng, Siying Zhang et autres
0 citationsmedRxiv
Wee Han Ng
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
44Publications signalées
1368Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Artificial Intelligence in Healthcare and EducationHepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and TreatmentClinical Reasoning and Diagnostic SkillsLiver Disease and Transplantation
Publications récentes
Real-world comparison of atezolizumab/bevacizumab vs durvalumab/tremelimumab in decompensated hepatocellular carcinoma.
Yuhan Chen, Wee Han Ng, Ting‐Hsuan Chiang, Emily Kaymen et autres
0 citationsJournal of Clinical Oncology
Association of pharmacotherapy with all-cause mortality among patients with irritable bowel syndrome
Sepideh Mehravar, Yee Hui Yeo, Mark Pimentel, Parnian Naji et autres
2 citationsCommunications Medicine
Safety and equity in scaling minimally invasive surgery worldwide in 109 countries using cholecystectomy as a tracer procedure: a prospective cohort study
Sivesh K. Kamarajah, Omar Kouli, Wee Han Ng, Riinu Pius et autres
2 citationsThe Lancet Global Health
212 Research Priorities for Cancers of the Oesophagus and Stomach: Recommendations from a United Kingdom & Ireland Patient and Healthcare Professional Partnership Exercise
Christopher Jones, Wee Han Ng, Laura Tincknell, Dylan Peter McClurg et autres
0 citationsBritish journal of surgery
Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise
Christopher M. Jones, Wee Han Ng, Laura Tincknell, Dylan Peter McClurg et autres
1 citationGut
Reply: Interpreting real-world data in advanced HCC—Need for clarity on subsequent therapies, adverse events, and follow-up adequacy
Joseph Ahn, Wee Han Ng, Yee Hui Yeo, Amit G. Singal et autres
0 citationsHepatology
Tu1617: CARVEDILOL IS ASSOCIATED WITH IMPROVED MAJOR ADVERSE LIVER-RELATED OUTCOMES COMPARED TO OTHER NON-SELECTIVE BETABLOCKERS IN COMPENSATED CIRRHOSIS
Ilora Naik, Yee Hui Yeo, Wee Han Ng, Aarshi Vipani et autres
0 citationsGastroenterology
Sa1539: LIPOPHILIC STATIN USE IS ASSOCIATED WITH A LOWER RISK OF HEPATOCELLULAR CARCINOMA IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)-RELATED CIRRHOSIS
Soo Young Hwang, Yee Hui Yeo, Wee Han Ng, Aarshi Vipani et autres
0 citationsGastroenterology
Carvedilol is associated with lower risk of hepatic decompensation compared to other non-selective beta-blockers in cirrhosis
Ilora Naik, Yee Hui Yeo, Wee Han Ng, Kevin Sheng‐Kai et autres
3 citationsJournal of Hepatology
Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction–associated steatotic liver diseases: Target trial emulation using real-world data
Wee Han Ng, Yee Hui Yeo, Hyun‐Seok Kim, Ekihiro Seki et autres
15 citationsHepatology
Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation
Joseph Ahn, Wee Han Ng, Yee Hui Yeo, Hyun‐Seok Kim et autres
15 citationsHepatology
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.